Toll-like receptor signaling in neonatal sepsis and inflammation: a matter of orchestration and conditioning

References

• Stoll BJ, Hansen N, Fanaroff AA et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110(2 Pt. 1), 285–291 (2002).
   PubMed Web of Science ®Google Scholar
• Stoll BJ, Hansen NI, Sanchez PJ et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics 127(5), 817–826 (2011).
   PubMed Web of Science ®Google Scholar
• Bersani I, Speer CP. Nosocomial sepsis in neonatal intensive care: inevitable or preventable? Z. Geburtshilfe Neonatol. 216(4), 186–190 (2012).
   PubMedGoogle Scholar
• Stoll BJ, Hansen N, Fanaroff AA et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N. Engl. J. Med. 347(4), 240–247 (2002).
   PubMed Web of Science ®Google Scholar
• Filias A, Theodorou GL, Mouzopoulou S, Varvarigou AA, Mantagos S, Karakantza M. Phagocytic ability of neutrophils and monocytes in neonates. BMC Pediatrics 11, 29 (2011).
   PubMedGoogle Scholar
• Urlichs F, Speer CP. Neutrophil function in preterm and term infants. NeoReviews 5(10), e417–e429 (2004).
   Google Scholar
• Wynn JL, Levy O. Role of innate host defenses in susceptibility to early-onset neonatal sepsis. Clin. Perinatol. 37(2), 307–337 (2010).
   PubMed Web of Science ®Google Scholar
• Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7(5), 379–390 (2007).
   PubMed Web of Science ®Google Scholar
• Chelvarajan RL, Collins SM, Doubinskaia IE et al. Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens. J. Leukoc. Biol. 75(6), 982–994 (2004).
   PubMed Web of Science ®Google Scholar
• Levy O, Zarember KA, Roy RM, Cywes C, Godowski PJ, Wessels MR. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J. Immunol. 173(7), 4627–4634 (2004).
   PubMedGoogle Scholar
• Angelone DF, Wessels MR, Coughlin M et al. Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo. Pediatr. Res. 60(2), 205–209 (2006).
   PubMed Web of Science ®Google Scholar
• Weatherstone KB, Rich EA. Tumor necrosis factor/cachectin and interleukin-1 secretion by cord blood monocytes from premature and term neonates. Pediatr. Res. 25(4), 342–346 (1989).
   PubMedGoogle Scholar
• Peters AM, Bertram P, Gahr M, Speer CP. Reduced secretion of interleukin-1 and tumor necrosis factor-alpha by neonatal monocytes. Biol. Neonate 63(3), 157–162 (1993).
   PubMedGoogle Scholar
• Wilson CB, Westall J, Johnston L, Lewis DB, Dower SK, Alpert AR. Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies. J. Clin. Invest. 77(3), 860–867 (1986).
   PubMed Web of Science ®Google Scholar
• Scott ME, Kubin M, Kohl S. High level interleukin-12 production, but diminished interferon-gamma production, by cord blood mononuclear cells. Pediatr. Res. 41(4 Pt. 1), 547–553 (1997).
   PubMedGoogle Scholar
• Peat EB, Augustine NH, Drummond WK, Bohnsack JF, Hill HR. Effects of fibronectin and group B streptococci on tumour necrosis factor-alpha production by human culture-derived macrophages. Immunology 84(3), 440–445 (1995).
   PubMedGoogle Scholar
• Berner R, Niemeyer CM, Leititis JU et al. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatr. Res. 44(4), 469–477 (1998).
   PubMed Web of Science ®Google Scholar
• Speer CP. Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia. Neonatology 95(4), 353–361 (2009).
   PubMedGoogle Scholar
• Speer CP. Neonatal respiratory distress syndrome: an inflammatory disease? Neonatology 99(4), 316–319 (2011).
   PubMed Web of Science ®Google Scholar
• Hunter CJ, Upperman JS, Ford HR, Camerini V. Understanding the susceptibility of the premature infant to necrotizing enterocolitis (NEC). Pediatr. Res. 63(2), 117–123 (2008).
   PubMed Web of Science ®Google Scholar
• Nanthakumar N, Meng D, Goldstein AM et al. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLoS ONE, 6(3), e17776 (2011).
   PubMed Web of Science ®Google Scholar
• Volpe JJ. Postnatal sepsis, necrotizing entercolitis, and the critical role of systemic inflammation in white matter injury in premature infants. J. Pediatr. 153(2), 160–163 (2008).
   PubMed Web of Science ®Google Scholar
• Khwaja O, Volpe JJ. Pathogenesis of cerebral white matter injury of prematurity. Arch. Dis. Child Fetal Neonatal Ed. 93(2), F153–F161 (2008).
   PubMed Web of Science ®Google Scholar
• Thomas W, Speer CP. Chorioamnionitis: important risk factor or innocent bystander for neonatal outcome? Neonatology 99(3), 177–187 (2011).
   PubMed Web of Science ®Google Scholar
• Nguyen CN, Schnulle PM, Chegini N, Luo X, Koenig JM. Neonatal neutrophils with prolonged survival secrete mediators associated with chronic inflammation. Neonatology 98(4), 341–347 (2010).
   PubMed Web of Science ®Google Scholar
• Kramer BW, Jobe AH, Ikegami M. Monocyte function in preterm, term, and adult sheep. Pediatr. Res. 54(1), 52–57 (2003).
   PubMedGoogle Scholar
• Harju K, Glumoff V, Hallman M. Ontogeny of Toll-like receptors Tlr2 and Tlr4 in mice. Pediatr. Res. 49(1), 81–83 (2001).
   PubMedGoogle Scholar
• Groneck P, Speer CP. Inflammatory mediators and bronchopulmonary dysplasia. Arch. Dis. Child Fetal Neonatal Ed. 73(1), F1–F3 (1995).
   PubMedGoogle Scholar
• Afrazi A, Sodhi CP, Richardson W et al. New insights into the pathogenesis and treatment of necrotizing enterocolitis: Toll-like receptors and beyond. Pediatr. Res. 69(3), 183–188 (2011).
   PubMedGoogle Scholar
• Nathan C. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6(3), 173–182 (2006).
   PubMed Web of Science ®Google Scholar
• Akira S. TLR signaling. Curr. Top Microbiol. Immunol. 311, 1–16 (2006).
   PubMed Web of Science ®Google Scholar
• Chen G, Shaw MH, Kim YG, Nunez G. NOD-like receptors: role in innate immunity and inflammatory disease. Annu. Rev. Pathol. 4, 365–398 (2009).
   PubMed Web of Science ®Google Scholar
• Meylan E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature 442(7098), 39–44 (2006).
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 140(6), 805–820 (2010).
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 449(7164), 819–826 (2007).
   PubMed Web of Science ®Google Scholar
• Miyake K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin. Immunol. 19(1), 3–10 (2007).
   PubMed Web of Science ®Google Scholar
• Nishiya T, Kajita E, Miwa S, Defranco AL. TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements. J. Biol. Chem. 280(44), 37107–37117 (2005).
   PubMedGoogle Scholar
• Takeuchi O, Hoshino K, Kawai T et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11(4), 443–451 (1999).
   PubMed Web of Science ®Google Scholar
• Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413(6857), 732–738 (2001).
   PubMed Web of Science ®Google Scholar
• Heil F, Hemmi H, Hochrein H et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303(5663), 1526–1529 (2004).
   PubMed Web of Science ®Google Scholar
• Chuang TH, Lee J, Kline L, Mathison JC, Ulevitch RJ. Toll-like receptor 9 mediates CpG-DNA signaling. J. Leukoc. Biol. 71(3), 538–544 (2002).
   PubMedGoogle Scholar
• Fusunyan RD, Nanthakumar NN, Baldeon ME, Walker WA. Evidence for an innate immune response in the immature human intestine: toll-like receptors on fetal enterocytes. Pediatr. Res. 49(4), 589–593 (2001).
   PubMedGoogle Scholar
• Chaudhuri N, Whyte MK, Sabroe I. Reducing the toll of inflammatory lung disease. Chest 131(5), 1550–1556 (2007).
   PubMed Web of Science ®Google Scholar
• Sadeghi K, Berger A, Langgartner M et al. Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J. Infect Dis. 195(2), 296–302 (2007).
   PubMedGoogle Scholar
• Xu Y, Tao X, Shen B et al. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408(6808), 111–115 (2000).
   PubMed Web of Science ®Google Scholar
• Jenkins KA, Mansell A. TIR-containing adaptors in Toll-like receptor signalling. Cytokine 49(3), 237–244 (2010).
   PubMedGoogle Scholar
• Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7(6), 837–847 (1997).
   PubMed Web of Science ®Google Scholar
• Wesche H, Gao X, Li X, Kirschning CJ, Stark GR, Cao Z. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J. Biol. Chem. 274(27), 19403–19410 (1999).
   PubMed Web of Science ®Google Scholar
• Takaesu G, Kishida S, Hiyama A et al. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol. Cell 5(4), 649–658 (2000).
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Takeda K. Current views of toll-like receptor signaling pathways. Gastroenterol. Res. Pract. 2010, 240365 (2010).
   PubMed Web of Science ®Google Scholar
• Karin M, Yamamoto Y, Wang QM. The IKK NF-kappa B system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3(1), 17–26 (2004).
   PubMed Web of Science ®Google Scholar
• Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6(9), 644–658 (2006).
   PubMed Web of Science ®Google Scholar
• Brint EK, Xu D, Liu H et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat. Immunol. 5(4), 373–379 (2004).
   PubMed Web of Science ®Google Scholar
• Burns K, Janssens S, Brissoni B, Olivos N, Beyaert R, Tschopp J. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197(2), 263–268 (2003).
   PubMed Web of Science ®Google Scholar
• Naiki Y, Michelsen KS, Zhang W, Chen S, Doherty TM, Arditi M. Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling. J. Biol. Chem. 280(7), 5491–5495 (2005).
   PubMedGoogle Scholar
• Nguyen HA, Rajaram MV, Meyer DA, Schlesinger LS. Pulmonary surfactant protein A and surfactant lipids upregulate IRAK-M, a negative regulator of TLR-mediated inflammation in human macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 303(7), L608–L616 (2012).
   PubMedGoogle Scholar
• LeBouder E, Rey-Nores JE, Rushmere NK et al. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J. Immunol. 171(12), 6680–6689 (2003).
   PubMed Web of Science ®Google Scholar
• Fukao T, Tanabe M, Terauchi Y et al. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 3(9), 875–881 (2002).
   PubMed Web of Science ®Google Scholar
• Riva F, Bonavita E, Barbati E, Muzio M, Mantovani A, Garlanda C. TIR8/SIGIRR is an interleukin-1 receptor/toll like receptor family member with regulatory functions in inflammation and immunity. Front. immunol. 3, 322 (2012).
   PubMed Web of Science ®Google Scholar
• Wietek C, Miggin SM, Jefferies CA, O’Neill LA. Interferon regulatory factor-3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-kappa. J. Biol. Chem. 278(51), 50923–50931 (2003).
   PubMedGoogle Scholar
• Feterowski C, Emmanuilidis K, Miethke T et al. Effects of functional Toll-like receptor-4 mutations on the immune response to human and experimental sepsis. Immunology 109(3), 426–431 (2003).
   PubMed Web of Science ®Google Scholar
• Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11(1), 115–122 (1999).
   PubMed Web of Science ®Google Scholar
• Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282(5396), 2085–2088 (1998).
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165(10), 5392–5396 (2000).
   PubMed Web of Science ®Google Scholar
• Arbour NC, Lorenz E, Schutte BC et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25(2), 187–191 (2000).
   PubMed Web of Science ®Google Scholar
• Ku CL, von Bernuth H, Picard C et al. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 204(10), 2407–2422 (2007).
   PubMed Web of Science ®Google Scholar
• Willet KE, Jobe AH, Ikegami M, Newnham J, Brennan S, Sly PD. Antenatal endotoxin and glucocorticoid effects on lung morphometry in preterm lambs. Pediatr. Res. 48(6), 782–788 (2000).
   PubMedGoogle Scholar
• Hillman NH, Moss TJ, Nitsos I et al. Toll-like receptors and agonist responses in the developing fetal sheep lung. Pediatr. Res. 63(4), 388–393 (2008).
   PubMedGoogle Scholar
• Petrikin JE, Gaedigk R, Leeder JS, Truog WE. Selective Toll--like receptor expression in human fetal lung. Pediatr. Res. 68(4), 335–338 (2010).
   PubMed Web of Science ®Google Scholar
• Forster-Waldl E, Sadeghi K, Tamandl D et al. Monocyte toll-like receptor 4 expression and LPS-induced cytokine production increase during gestational aging. Pediatr. Res. 58(1), 121–124 (2005).
   PubMed Web of Science ®Google Scholar
• Kollmann TR, Levy O, Montgomery RR, Goriely S. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 37(5), 771–783 (2012).
   PubMed Web of Science ®Google Scholar
• Thornton NL, Cody MJ, Yost CC. Toll-like receptor 1/2 stimulation induces elevated interleukin-8 secretion in polymorphonuclear leukocytes isolated from preterm and term newborn infants. Neonatology 101(2), 140–146 (2012).
   PubMedGoogle Scholar
• Al-Hertani W, Yan SR, Byers DM, Bortolussi R. Human newborn polymorphonuclear neutrophils exhibit decreased levels of MyD88 and attenuated p38 phosphorylation in response to lipopolysaccharide. Clin. Invest. Med. 30(2), E44–E53 (2007).
   PubMedGoogle Scholar
• Dasari P, Zola H, Nicholson IC. Expression of Toll-like receptors by neonatal leukocytes. Pediatr. Allergy. Immunol. 22(2), 221–228 (2011).
   PubMedGoogle Scholar
• Tulic MK, Hodder M, Forsberg A et al. Differences in innate immune function between allergic and nonallergic children: new insights into immune ontogeny. J. Allergy Clin. Immunol. 127(2), 470–478 e1 (2011).
   PubMedGoogle Scholar
• Bonner S, Yan SR, Byers DM, Bortolussi R. Activation of extracellular signal-related protein kinases 1 and 2 of the mitogen-activated protein kinase family by lipopolysaccharide requires plasma in neutrophils from adults and newborns. Infect. Immun. 69(5), 3143–3149 (2001).
   PubMedGoogle Scholar
• Nathe KE, Mancuso CJ, Parad R et al. Innate immune activation in neonatal tracheal aspirates suggests endotoxin-driven inflammation. Pediatr. Res. 72(2), 203–211 (2012).
   PubMedGoogle Scholar
• Viemann D, Dubbel G, Schleifenbaum S, Harms E, Sorg C, Roth J. Expression of toll-like receptors in neonatal sepsis. Pediatr. Res. 58(4), 654–659 (2005).
   PubMedGoogle Scholar
• Yan SR, Qing G, Byers DM, Stadnyk AW, Al-Hertani W, Bortolussi R. Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide. Infect. Immun. 72(3), 1223–1229 (2004).
   PubMedGoogle Scholar
• Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 353(9148), 196–200 (1999).
   PubMed Web of Science ®Google Scholar
• Reece P, Thanendran A, Crawford L et al. Maternal allergy modulates cord blood hematopoietic progenitor Toll-like receptor expression and function. J. Allergy Clin. Immunol. 127(2), 447–453 (2011).
   PubMedGoogle Scholar
• Williams DL, Ha T, Li C et al. Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit. Care Med. 31(6), 1808–1818 (2003).
   PubMed Web of Science ®Google Scholar
• Marsik C, Mayr F, Cardona F, Derhaschnig U, Wagner OF, Jilma B. Endotoxaemia modulates Toll-like receptors on leucocytes in humans. Br. J. Haematol. 121(4), 653–656 (2003).
   PubMedGoogle Scholar
• Armstrong L, Medford AR, Hunter KJ, Uppington KM, Millar AB. Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin. Exp. Immunol. 136(2), 312–319 (2004).
   PubMedGoogle Scholar
• Zhang JP, Yang Y, Levy O, Chen C. Human neonatal peripheral blood leukocytes demonstrate pathogen-specific coordinate expression of TLR2, TLR4/MD2, and MyD88 during bacterial infection in vivo. Pediatr. Res. 68(6), 479–483 (2010).
   PubMedGoogle Scholar
• Yerkovich ST, Wikstrom ME, Suriyaarachchi D, Prescott SL, Upham JW, Holt PG. Postnatal development of monocyte cytokine responses to bacterial lipopolysaccharide. Pediatr. Res. 62(5), 547–552 (2007).
   PubMed Web of Science ®Google Scholar
• Henneke P, Osmers I, Bauer K, Lamping N, Versmold HT, Schumann RR. Impaired CD14-dependent and independent response of polymorphonuclear leukocytes in preterm infants. J. Perinat. Med. 31(2), 176–183 (2003).
   PubMed Web of Science ®Google Scholar
• Levy O, Coughlin M, Cronstein BN, Roy RM, Desai A, Wessels MR. The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J. Immunol. 177(3), 1956–1966 (2006).
   PubMedGoogle Scholar
• Caron JE, La Pine TR, Augustine NH, Martins TB, Hill HR. Multiplex analysis of toll-like receptor-stimulated neonatal cytokine response. Neonatology 97(3), 266–273 (2010).
   PubMed Web of Science ®Google Scholar
• Kollmann TR, Crabtree J, Rein-Weston A et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J. Immunol. 183(11), 7150–7160 (2009).
   PubMed Web of Science ®Google Scholar
• Wynn JL, Scumpia PO, Delano MJ et al. Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock 28(6), 675–683 (2007).
   PubMedGoogle Scholar
• Wynn JL, Scumpia PO, Winfield RD et al. Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood 112(5), 1750–1758 (2008).
   PubMedGoogle Scholar
• Azizia M, Lloyd J, Allen M, Klein N, Peebles D. Immune status in very preterm neonates. Pediatrics 129(4), e967–e974 (2012).
   PubMedGoogle Scholar
• Lisciandro JG, Prescott SL, Nadal-Sims MG et al. Ontogeny of Toll-like and NOD-like receptor-mediated innate immune responses in Papua New Guinean infants. PLoS ONE 7(5), e36793 (2012).
   PubMed Web of Science ®Google Scholar
• Levy O, Jean-Jacques RM, Cywes C et al. Critical role of the complement system in group B streptococcus-induced tumor necrosis factor alpha release. Infect. Immun. 71(11), 6344–e6353 (2003).
   PubMedGoogle Scholar
• Berner R, Welter P, Brandis M. Cytokine expression of cord and adult blood mononuclear cells in response to Streptococcus agalactiae. Pediatr. Res. 51(3), 304–309 (2002).
   PubMedGoogle Scholar
• Dollner H, Vatten L, Linnebo I, Zanussi GF, Laerdal A, Austgulen R. Inflammatory mediators in umbilical plasma from neonates who develop early-onset sepsis. Biol. Neonate 80(1), 41–47 (2001).
   PubMedGoogle Scholar
• Lalor MK, Ben-Smith A, Gorak-Stolinska P et al. Population differences in immune responses to Bacille Calmette-Guerin vaccination in infancy. J. Infect. Dis. 199(6), 795–800 (2009).
   PubMedGoogle Scholar
• Philbin VJ, Levy O. Developmental biology of the innate immune response: implications for neonatal and infant vaccine development. Pediatr. Res. 65(5 Pt. 2), 98R–105R (2009).
   PubMedGoogle Scholar
• Levy O. Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists. J. Endotoxin Res. 11(2), 113–116 (2005).
   PubMedGoogle Scholar
• Belderbos ME, Houben ML, van Bleek GM et al. Breastfeeding modulates neonatal innate immune responses: a prospective birth cohort study. Pediatr. Allergy Immunol. 23(1), 65–74 (2012).
   PubMedGoogle Scholar
• Belderbos ME, Levy O, Stalpers F, Kimpen JL, Meyaard L, Bont L. Neonatal plasma polarizes TLR4-mediated cytokine responses towards low IL-12p70 and high IL-10 production via distinct factors. PLoS ONE. 7(3), e33419 (2012).
   PubMedGoogle Scholar
• Molloy EJ, O’Neill AJ, Doyle BT et al. Effects of heat shock and hypoxia on neonatal neutrophil lipopolysaccharide responses: altered apoptosis, Toll-like receptor-4 and CD11b expression compared with adults. Biol. Neonate 90(1), 34–39 (2006).
   PubMedGoogle Scholar
• Speer CP, Gahr M, Wieland M, Eber S. Phagocytosis-associated functions in neonatal monocyte-derived macrophages. Pediatr. Res. 24(2), 213–216 (1988).
   PubMedGoogle Scholar
• Zentay Z, Sharaf M, Qadir M, Drafta D, Davidson D. Mechanism for dexamethasone inhibition of neutrophil migration upon exposure to lipopolysaccharide in vitro: role of neutrophil interleukin-8 release. Pediatr. Res. 46(4), 406–410 (1999).
   PubMedGoogle Scholar
• Contrino J, Krause PJ, Slover N, Kreutzer D. Elevated interleukin-1 expression in human neonatal neutrophils. Pediatr. Res. 34(3), 249–252 (1993).
   PubMedGoogle Scholar
• May M, Marx A, Seidenspinner S, Speer CP. Apoptosis and proliferation in lungs of human fetuses exposed to chorioamnionitis. Histopathology 45(3), 283–290 (2004).
   PubMedGoogle Scholar
• Henning LN, Azad AK, Parsa KV, Crowther JE, Tridandapani S, Schlesinger LS. Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages. J. Immunol. 180(12), 7847–7858 (2008).
   PubMed Web of Science ®Google Scholar
• Bersani I, Kunzmann S, Speer CP. Immunomodulatory properties of surfactant preparations. Expert Rev. Anti Infect. Ther. 11(1), 99–110 (2013).
   PubMed Web of Science ®Google Scholar
• Bersani I, Speer CP, Kunzmann S. Surfactant proteins A and D in pulmonary diseases of preterm infants. Expert Rev. Anti Infect. Ther. 10(5), 573–584 (2012).
   PubMed Web of Science ®Google Scholar
• Fan H, Cook JA. Molecular mechanisms of endotoxin tolerance. J. Endotoxin Res. 10(2), 71–84 (2004).
   PubMedGoogle Scholar
• Kallapur SG, Jobe AH, Ball MK et al. Pulmonary and systemic endotoxin tolerance in preterm fetal sheep exposed to chorioamnionitis. J. Immunol. 179(12), 8491–8499 (2007).
   PubMed Web of Science ®Google Scholar
• Kramer BW, Ikegami M, Moss TJ, Nitsos I, Newnham JP, Jobe AH. Endotoxin-induced chorioamnionitis modulates innate immunity of monocytes in preterm sheep. Am. J. Respir. Crit. Care Med. 171(1), 73–77 (2005).
   PubMedGoogle Scholar
• Claud EC, Lu L, Anton PM, Savidge T, Walker WA, Cherayil BJ. Developmentally regulated IkappaB expression in intestinal epithelium and susceptibility to flagellin-induced inflammation. Proc. Natl Acad. Sci. USA 101(19), 7404–7408 (2004).
   PubMed Web of Science ®Google Scholar
• Leaphart CL, Cavallo J, Gribar SC et al. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J. Immunol. 179(7), 4808–4820 (2007).
   PubMed Web of Science ®Google Scholar
• Chan KL, Wong KF, Luk JM. Role of LPS/CD14/TLR4-mediated inflammation in necrotizing enterocolitis: pathogenesis and therapeutic implications. World J. Gastroenterol. 15(38), 4745–4752 (2009).
   Google Scholar
• Wang J, Ford HR, Grishin AV. NF-kappaB-mediated expression of MAPK phosphatase-1 is an early step in desensitization to TLR ligands in enterocytes. Mucosal Immunol. 3(5), 523–534 (2010).
   PubMedGoogle Scholar
• Sodhi CP, Shi XH, Richardson WM et al. Toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis. Gastroenterology 138(1), 185–196 (2010).
   PubMed Web of Science ®Google Scholar
• De Wit D, Olislagers V, Goriely S et al. Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 103(3), 1030–1032 (2004).
   PubMed Web of Science ®Google Scholar
• Kotiranta-Ainamo A, Apajasalo M, Pohjavuori M, Rautonen N, Rautonen J. Mononuclear cell subpopulations in preterm and full-term neonates: independent effects of gestational age, neonatal infection, maternal pre-eclampsia, maternal betamethason therapy, and mode of delivery. Clin. Exp. Immunol. 115(2), 309–314 (1999).
   PubMedGoogle Scholar
• Landmann R, Knopf HP, Link S, Sansano S, Schumann R, Zimmerli W. Human monocyte CD14 is upregulated by lipopolysaccharide. Infect. Immun. 64(5), 1762–1769 (1996).
   PubMed Web of Science ®Google Scholar
• Bhakdi S, Klonisch T, Nuber P, Fischer W. Stimulation of monokine production by lipoteichoic acids. Infect. Immun. 59(12), 4614–4620 (1991).
   PubMed Web of Science ®Google Scholar
• Polin RA, Committee on F, Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 129(5), 1006–1015 (2012).
   PubMed Web of Science ®Google Scholar